THE SHARE: Change: +0.00 SEK (+0.55%) / Price: 0.18 SEK / May 21, 2025, 5:25 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Spago Nanomedical in media

  • 5 Mar, 2021
    Spago Nanomedical om den övertecknade emissionen och planen framåt – BioStock
  • 15 Feb, 2021
    Genombrott för nanomedicinsk cancerterapi – Affärsvärlden
  • 15 Feb, 2021
    Spago Nanomedical växlar upp med Tumorad – BioStock
  • 9 Feb, 2021
    Spago Nanomedical – Plattformsteknologi inom cancerbehandling och diagnostik tar steget mot First North – Börskollen
  • 8 Feb, 2021
    Säkerställd emission och listbyte för Spago Nanomedical – BioStock
  • 21 Jan, 2021
    Presentationer i samband med nyemission
  • 13 Nov, 2020
    Webbcast 12 november, 2020
  • 12 Nov, 2020
    Tydliga bilder i klinisk studie med SpagoPix
  • 27 Oct, 2020
    Spago Nanomedical presenterar på Redeye Investor Forum Online den 12 november
  • 8 Oct, 2020
    Spago Nanomedicals presentation på Erik Pensers Cancer Day
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 19
  • Previous
  • Next
Back
  • Spago Nanomedical in media
  • Press Releases
  • Subscribe
  • Presentations
  • Events
  • Image Bank

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2025 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications